Temporomandibular Joint Disorders JENNIFER J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Juvenile Recurrent Parotitis and Sialolithiasis: an Noteworthy Co-Existence
Otolaryngology Open Access Journal ISSN: 2476-2490 Juvenile Recurrent Parotitis and Sialolithiasis: An Noteworthy Co-Existence Venkata NR* and Sanjay H Case Report Department of ENT and Head & Neck Surgery, Kohinoor Hospital, India Volume 3 Issue 1 Received Date: April 20, 2018 *Corresponding author: Nataraj Rajanala Venkata, Department of ENT and Head & Published Date: May 21, 2018 Neck Surgery, Kohinoor Hospital, Kurla (W), Mumbai, India, Tel: +918691085580; DOI: 10.23880/ooaj-16000168 Email: [email protected] Abstract Juvenile Recurrent Parotitis is a relatively rare condition. Sialolithiasis co-existing along with Juvenile Recurrent Parotitis is an even rarer occurrence. We present a case of Juvenile Recurrent Parotitis and Sialolithiasis in a 6 years old male child and how we managed it. Keywords: Juvenile Recurrent Parotitis; Parotid gland; Swelling; Sialolithiasis Introduction child. Tuberculosis was suspected but the tests yielded no results. Even MRI of the parotid gland failed to reveal any Juvenile Recurrent Parotitis is characterized by cause. Then the patient was referred to us for definitive recurring episodes of swelling usually accompanied by management. Taking the history into consideration, a pain in the parotid gland. Associated symptoms usually probable diagnosis of Juvenile Recurrent Parotitis due to include fever and malaise. It is most commonly seen in sialectasis was considered. CT Sialography revealed children, but may persist into adulthood. Unlike parotitis, dilatation of the main duct and the ductules with which is caused by infection or obstructive causes like collection of the dye at the termination of the terminal calculi, fibromucinous plugs, duct stenosis and foreign ductules, in the left parotid gland. -
Sjogren's Syndrome an Update on Disease Pathogenesis, Clinical
Clinical Immunology 203 (2019) 81–121 Contents lists available at ScienceDirect Clinical Immunology journal homepage: www.elsevier.com/locate/yclim Review Article Sjogren’s syndrome: An update on disease pathogenesis, clinical T manifestations and treatment ⁎ Frederick B. Vivinoa, , Vatinee Y. Bunyab, Giacomina Massaro-Giordanob, Chadwick R. Johra, Stephanie L. Giattinoa, Annemarie Schorpiona, Brian Shaferb, Ammon Peckc, Kathy Sivilsd, ⁎ Astrid Rasmussend, John A. Chiorinie, Jing Hef, Julian L. Ambrus Jrg, a Penn Sjögren's Center, Penn Presbyterian Medical Center, University of Pennsylvania Perelman School of Medicine, 3737 Market Street, Philadelphia, PA 19104, USA b Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 N. 39th Street, Philadelphia, PA 19104, USA c Department of Infectious Diseases and Immunology, University of Florida College of Veterinary Medicine, PO Box 100125, Gainesville, FL 32610, USA d Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology Program, 825 NE 13th Street, OK 73104, USA e NIH, Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, Building 10, Room 1n113, 10 Center DR Msc 1190, Bethesda, MD 20892-1190, USA f Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China g Division of Allergy, Immunology and Rheumatology, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203, USA 1. Introduction/History and lacrimal glands [4,11]. The syndrome is named, however, after an Ophthalmologist from Jonkoping, Sweden, Dr Henrik Sjogren, who in Sjogren’s syndrome (SS) is one of the most common autoimmune 1930 noted a patient with low secretions from the salivary and lacrimal diseases. It may exist as either a primary syndrome or as a secondary glands. -
Parotid Sialolithiasis and Sialadenitis in a 3-Year-Old Child
Ahmad Tarmizi et al. Egyptian Pediatric Association Gazette (2020) 68:29 Egyptian Pediatric https://doi.org/10.1186/s43054-020-00041-z Association Gazette CASE REPORT Open Access Parotid sialolithiasis and sialadenitis in a 3- year-old child: a case report and review of the literature Nur Eliana Ahmad Tarmizi1, Suhana Abdul Rahim2, Avatar Singh Mohan Singh2, Lina Ling Chooi2, Ong Fei Ming2 and Lum Sai Guan1* Abstract Background: Salivary gland calculi are common in adults but rare in the paediatric population. It accounts for only 3% of all cases of sialolithiasis. Parotid ductal calculus is rare as compared to submandibular ductal calculus. Case presentation: A 3-year-old boy presented with acute painful right parotid swelling with pus discharge from the Stensen duct. Computed tomography revealed calculus obstructing the parotid duct causing proximal ductal dilatation and parotid gland and masseter muscle oedema. The child was treated with conservative measures, and subsequently the swelling and calculus resolved. Conclusions: Small parotid duct calculus in children may be successfully treated with conservative measures which obviate the need for surgery. We discuss the management of parotid sialolithiasis in children and conduct literature search on the similar topic. Keywords: Sialolithiasis, Sialadenitis, Salivary calculi, Parotid gland, Salivary ducts, Paediatrics Background performing computed tomography (CT) of the neck. Sialolithiasis is an obstructive disorder of salivary ductal The unusual presentation, CT findings and its subse- system caused by formation of stones within the salivary quent management were discussed. gland or its excretory duct [1]. The resulting salivary flow obstruction leads to salivary ectasia, gland dilatation Case presentation and ascending infection [2]. -
Orofacial Manifestations of COVID-19: a Brief Review of the Published Literature
CRITICAL REVIEW Oral Pathology Orofacial manifestations of COVID-19: a brief review of the published literature Esam HALBOUB(a) Abstract: Coronavirus disease 2019 (COVID-19) has spread Sadeq Ali AL-MAWERI(b) exponentially across the world. The typical manifestations of Rawan Hejji ALANAZI(c) COVID-19 include fever, dry cough, headache and fatigue. However, Nashwan Mohammed QAID(d) atypical presentations of COVID-19 are being increasingly reported. Saleem ABDULRAB(e) Recently, a number of studies have recognized various mucocutaneous manifestations associated with COVID-19. This study sought to (a) Jazan University, College of Dentistry, summarize the available literature and provide an overview of the Department of Maxillofacial Surgery and potential orofacial manifestations of COVID-19. An online literature Diagnostic Sciences, Jazan, Saudi Arabia. search in the PubMed and Scopus databases was conducted to retrieve (b) AlFarabi College of Dentistry and Nursing, the relevant studies published up to July 2020. Original studies Department of Oral Medicine and published in English that reported orofacial manifestations in patients Diagnostic Sciences, Riyadh, Saudi Arabia. with laboratory-confirmed COVID-19 were included; this yielded 16 (c) AlFarabi College of Dentistry and Nursing, articles involving 25 COVID-19-positive patients. The results showed a Department of Oral Medicine and Diagnostic Sciences, Riyadh, Saudi Arabia. marked heterogeneity in COVID-19-associated orofacial manifestations. The most common orofacial manifestations were ulcerative lesions, (d) AlFarabi College of Dentistry and Nursing, Department of Restorative Dental Sciences, vesiculobullous/macular lesions, and acute sialadentitis of the parotid Riyadh, Saudi Arabia. gland (parotitis). In four cases, oral manifestations were the first signs of (e) Primary Health Care Corporation, Madinat COVID-19. -
Oral Manifestations of Systemic Disease Their Clinical Practice
ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease. -
Applied Anatomy of the Temporomandibular Joint
Applied anatomy of the temporomandibular joint CHAPTER CONTENTS process which, together with the temporal process of the zygo- Bones . e198 matic bone, forms the zygomatic arch (Fig. 1). The midline fusion of the left and right mandibular bodies Joint .capsule .and .ligaments . e198 provides a connection between the two temporomandibular Intra-articular .meniscus . e198 joints, so that movement in one joint always influences the opposite one. Nociceptive .innervation . e199 Muscles .and .tendons . e199 Joint capsule and ligaments Biomechanical .aspects . e200 Forward movement of the mandible . e200 The joint capsule is wide and loose on the upper aspect around Opening and closing the mouth. e200 the mandibular fossa. Distally, it diminishes in a funnel shaped Grinding movements . e200 manner to become attached to the mandibular neck (Fig. 2). Nerves .and .blood .vessels . e200 Its laxity prevents rupture even after dislocation. Laterally and medially, a local reinforcement of the joint capsule is found. The lateral collateral ligament courses from The temporomandibular joint (TMJ) is sited at the base of the the zygomatic arch obliquely downwards and backwards skull and formed by parts of the mandible and the temporal towards the posterior rim of the mandibular neck, lateral to bone, separated by an intra-articular meniscus. It is a synovial the outer aspect of the capsule. At its posterior aspect, it is in joint capable of both hinge (rotation) and sliding (translatory) close relation to the joint capsule and prevents the joint from movements. Like other synovial joints, it may be affected by opening widely. Medially, the joint capsule is locally reinforced internal derangement, inflammatory arthritis, arthrosis, and by the medial collateral ligament. -
Innervation of the Temporomandibular Joint Can Be Discussed It Is Necessary First to Describe Its Embryology, Gfoss Anatomy and Microscopic Appe¿Ìrance
à8.ì 'R? INNERVATION OF THE TEMPOROMAI\DIBULAR J AN EXPERIMENTAL AMMAL MODEL USING AUSTRALIAN MERINO STIEEP ABDOLGHAFAR TAHMASEBI-SARVESTANI' B. Sc, M. Sc Thesis submitted for the degree of DOCTOR OF PHILOSOPHY In The Department of Anatomical Sciences The University of Adelaide (Faculty of Medicine)' Adelaide, South Australia, 5005 April, L997 tfüs tñesisis [elicatelø nl wtfe Aggñleñ ø¡tlour g4.arzi"e tfr.re e c friûfren Ía fiera ñ, fo zic ñ atú fi l-1 ACKNOWLEDGMENTS I am greatly indebted to my supervisors Dr. Ray Tedman and Professor Alastair Goss who first inrroduced me to this freld of study and providing me with the opportunity to carry out this work. I wish to thank them for their constant interest and guidance throughout the course of this study. I am also indebted to the scholarship committee of the Shiraz Medical Science University and Ministry of Health and Medical Education, Iran for gânting me a 4 year scholarship to study at the Universiry of Adelaide. I thank professor Goss and the Japanese Surgical Research team for their expertise in surgical animal models, and Professor July Polak and Dr Mika Hukkanen, Royal postgraduate Medical School London University for their expertise in immunohistochemistry and for providing some of the antisera used in the neuropeptide studies. I would also like to thank Professor Ian Gibbins, Department of Anatomy and Histology of the Flinders Medical Centre for, without the use of his laboratories, materials, and expertise, the double and triple labelling parts of the immunocytochemical work would not have occurred. I also orwe many thanks to Susan Matthew, a senior laboratory officer for her skilful technical assistance in double and triple immunocytochemistry. -
For Immediate Release
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and CEO (Code no.: 4568, First Section, Tokyo, Osaka, and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, General Manager, Corporate Communications Department Telephone: +81-3-6225-1126 http://www.daiichisankyo.com/ Daiichi Sankyo Launches new Cravit® Formulations in Japan TOKYO, Japan (July 7, 2009) – Daiichi Sankyo Company, Limited (TSE: 4568), today launched new formulations of Cravit® (generic name: Levofloxacin Hydrate), a broad-spectrum oral anti-bacterial agent. These formulations are 500mg and 250mg tablets, and a 10% fine granular preparation in Japan. The company obtained manufacturing and marketing approval on April 22. The drug price listing was on June 19. Daiichi Sankyo drew on PK-PD theory (see note below) to develop the once-daily dosage for the 500mg Cravit® tablet. This tablet lifts the maximum blood concentration and is significantly more bactericidal than the 100mg formulation, taken three times daily, suppressing the development of drug-resistant bacteria. The once-daily dosage of the Cravit® 500mg tablet is an approved standard in more than 120 countries and territories. Since its introduction in December 1993 in Japan, Cravit® has gained approval for treating 43 indications and 32 bacteria. This agent continues to offer outstanding efficacy, and has won accolades for its safety profile. Daiichi Sankyo is confident that its concept of a once-daily dosage of a 500mg tablet will win broad acceptance for improved efficacy and a better suppression of strong bacteria. The company will cultivate this product as a worthy contributor to long-term treatment. -
Diagnosis and Treatment of Temporomandibular Disorders ROBERT L
Diagnosis and Treatment of Temporomandibular Disorders ROBERT L. GAUER, MD, and MICHAEL J. SEMIDEY, DMD, Womack Army Medical Center, Fort Bragg, North Carolina Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and neuromuscular conditions involving the temporomandibular joint complex, and surrounding musculature and osseous components. TMD affects up to 15% of adults, with a peak incidence at 20 to 40 years of age. TMD is classified asintra-articular or extra- articular. Common symptoms include jaw pain or dysfunction, earache, headache, and facial pain. The etiology of TMD is multifactorial and includes biologic, environmental, social, emotional, and cognitive triggers. Diagnosis is most often based on history and physical examination. Diagnostic imaging may be beneficial when malocclusion or intra-articular abnormalities are suspected. Most patients improve with a combination of noninvasive therapies, including patient education, self-care, cognitive behavior therapy, pharmacotherapy, physical therapy, and occlusal devices. Nonsteroidal anti-inflammatory drugs and muscle relaxants are recommended initially, and benzodiazepines or antidepressants may be added for chronic cases. Referral to an oral and maxillofacial surgeon is indicated for refrac- tory cases. (Am Fam Physician. 2015;91(6):378-386. Copyright © 2015 American Academy of Family Physicians.) More online he temporomandibular joint (TMJ) emotional, and cognitive triggers. Factors at http://www. is formed by the mandibular con- consistently associated with TMD include aafp.org/afp. dyle inserting into the mandibular other pain conditions (e.g., chronic head- CME This clinical content fossa of the temporal bone. Muscles aches), fibromyalgia, autoimmune disor- conforms to AAFP criteria Tof mastication are primarily responsible for ders, sleep apnea, and psychiatric illness.1,3 for continuing medical education (CME). -
ADVERSE FACTORS THAT CAN AFFECT on the COURSE of CHRONIC PARENCHIMATIC PAROTITIS in CHILDREN DOI: 10.36740/Wlek202006118
© Aluna Publishing Wiadomości Lekarskie, VOLUME LXXIII, ISSUE 6, JUNE 2020 ORIGINAL ARTICLE ADVERSE FACTORS THAT CAN AFFECT ON THE COURSE OF CHRONIC PARENCHIMATIC PAROTITIS IN CHILDREN DOI: 10.36740/WLek202006118 Pavlo I. Tkachenko, Serhii O. Bilokon, Yuliia V. Popelo, Nataliia M. Lokhmatova, Olha B. Dolenko, Nataliia M. Korotych UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE ABSTRACT The aim: The study of the presence of disorders in the ante- and postnatal periods of development of children from 2 months to 15 years with chronic parenchimatic parotitis, which may affect its course. Materials and methods: It has been examined and treated 88 children, aged from 2 months to 15 years with chronic parenchimatic parotitis, and their mothers were interviewed, who indicated the pathological course of pregnancy, childbirth and indicated the type of breastfeeding babbies. The scope of the survey included general, additional methods, consultations by related specialists and statistical processing of results. Results: 88 children with the exacerbation of chronic parenchimatic parotitis were examined (42 – (47%) with active course and 46 – (53%) with inactive). The exacerbation occurred on the background of acute infectious processes or coincided with the exacerbation of one of the chronic diseases. The first manifestations occurred in spring (55%) and autumn (36%) periods, 44% of children were hospitalized with other diagnoses. The presence of pathological conditions during pregnancy and birth defects in their mothers were recorded more often 3,5 and 3,3 times, respectively, compared with control. 70% of children received mixed and artificial feeding and were more likely to become ill. Conclusions: The severity of clinical manifestations of inflammation and disorders of the general condition depended on the activity of the course of chronic parenchimatic parotitis and were more pronounced when active. -
Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases
Journal of Clinical Medicine Review Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases Barbora Hocková 1,2,†, Abanoub Riad 3,4,*,† , Jozef Valky 5, Zuzana Šulajová 5, Adam Stebel 1, Rastislav Slávik 1, Zuzana Beˇcková 6,7, Andrea Pokorná 3,8 , Jitka Klugarová 3,4 and Miloslav Klugar 3,4 1 Department of Maxillofacial Surgery, F. D. Roosevelt University Hospital, 975 17 Banska Bystrica, Slovakia; [email protected] (B.H.); [email protected] (A.S.); [email protected] (R.S.) 2 Department of Prosthetic Dentistry, Faculty of Medicine and Dentistry, Palacky University, 775 15 Olomouc, Czech Republic 3 Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic; [email protected] (A.P.); [email protected] (J.K.); [email protected] (M.K.) 4 Department of Public Health, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic 5 Department of Anaesthesiology, F. D. Roosevelt University Hospital, 975 17 Banska Bystrica, Slovakia; [email protected] (J.V.); [email protected] (Z.Š.) 6 Department of Clinical Microbiology, F. D. Roosevelt University Hospital, 975 17 Banska Bystrica, Slovakia; [email protected] 7 St. Elizabeth University of Health and Social Work, 812 50 Bratislava, Slovakia 8 Department of Nursing and Midwifery, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic * Correspondence: [email protected]; Tel.: +420-721-046-024 † These authors contributed equally to this work. -
Diagnosing and Treating Trigeminal Neuralgia in General Dentistry
general practice feature Chasing Pain Diagnosing and Treating Trigeminal Neuralgia in General Dentistry by Steven Olmos, DDS, DABCP, DABCDSM, DABDSM, DAAPM, FAAOP, FAACP, FICCMO, FADI, FIAO As dentists, we know quite a bit about tooth and gum pain, but when it comes to chronic facial pain and neuropathic pain, our dental school education leaves us unprepared. The objective of this article is to explain the differences between men and women with chronic orofacial pain and the relationship to proper functional breathing, using a case study as demonstration. 34 JANUARY 2016 // dentaltown.com general practice feature the United States, nearly half research published in Chest 2015 demonstrates that of all adults lived with chronic respiratory-effort-related arousal may be the most pain in 2011. Of 353,000 adults likely cause (nasal obstruction or mouth breath- 11 aged 18 years or older who were ing). Rising C02 (hypercapnia) in a patient with a surveyed by Gallup-Health- sleep-breathing disorder (including mouth breath- ways, 47 percent reported having at least one of ing) specifically stimulates the superficial masseter three types of chronic pain: neck or back pain, muscles to contract.12 knee or leg pain, or recurring pain.2 Identifying the structural area of obstruction A study published in The Journal of the Amer- (Four Points of Obstruction; Fig. 1) of the air- ican Dental Association October 2015 stated: way will insure the most effective treatment for a “One in six patients visiting a general dentist had sleep-breathing disorder and effectively reduce the experienced orofacial pain during the last year.